Continuum Advisory’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-770
Closed -$84.4K 737
2025
Q1
$84.4K Sell
770
-10,606
-93% -$1.28M 0.01% 553
2024
Q4
$1.41M Buy
11,376
+271
+2% +$32.9K 0.18% 115
2024
Q3
$1.43M Sell
11,105
-468
-4% -$50.4K 0.18% 120
2024
Q2
$1.27M Buy
11,573
+906
+8% +$100K 0.18% 124
2024
Q1
$1.23M Sell
10,667
-5,337
-33% -$548K 0.18% 127
2023
Q4
$1.56M Buy
16,004
+1,405
+10% +$129K 0.22% 117
2023
Q3
$1.41M Buy
14,599
+9,479
+185% +$903K 0.23% 116
2023
Q2
$463K Sell
5,120
-27
-0.5% -$2.27K 0.07% 297
2023
Q1
$449K Buy
5,147
+35
+0.7% +$3.06K 0.08% 283
2022
Q4
$491K Sell
5,112
-106
-2% -$9.53K 0.09% 257
2022
Q3
$382K Sell
5,218
-532
-9% -$44.2K 0.07% 285
2022
Q2
$457K Sell
5,750
-166
-3% -$14.6K 0.08% 265
2022
Q1
$534K Buy
5,916
+2,175
+58% +$206K 0.1% 233
2021
Q4
$348K Buy
3,741
+12
+0.3% +$1.13K 0.08% 227
2021
Q3
$351K Buy
3,729
+140
+4% +$14K 0.09% 205
2021
Q2
$345K Buy
+3,589
New +$337K 0.11% 195
2018
Q1
Sell
-2,883
Closed -$201K 147
2017
Q4
$201K Buy
+2,883
New +$187K 0.15% 165

Other funds holding EMR

Continuum Advisory's EMR Position: Q2 2025 in Review

Continuum Advisory sold out of Emerson Electric (EMR) in Q2 2025, closing a stake of 770 shares — an estimated $84.4K sold.

Continuum Advisory first reported a position in EMR in Q4 2017 and held it in 17 quarters. The position peaked at $1.56M in Q4 2023. 2,135 funds tracked by Wall St. Rank hold EMR as of Q2 2025.

  • Continuum Advisory reported no remaining Emerson Electric position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 770 Emerson Electric shares in Q2 2025, an estimated $84.4K.
  • Continuum Advisory first reported a position in Emerson Electric in Q4 2017 and held it in 17 quarters.
  • Continuum Advisory's Emerson Electric position peaked at $1.56M in Q4 2023.
  • 2,135 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.